Search tips
Search criteria 


Logo of annaldermaThis ArticleThis JournalAboutInformation for AuthorsOnline SubmissionAnnals of Dermatology
Ann Dermatol. 2011 October; 23(Suppl 2): S193–S196.
Published online 2011 October 31. doi:  10.5021/ad.2011.23.S2.S193
PMCID: PMC3229063

Birt-Hogg-Dubé Syndrome, a Rare Case in Korea Confirmed by Genetic Analysis


Simple benign tumors can present as part of a syndrome with substantial mortality. Fibrofolliculomas are benign skin tumors most often associated with the Birt-Hogg-Dubé syndrome (BHDS). The most life-threatening complication of this syndrome is renal cancer and other major features include multiple lung cysts and spontaneous pneumothorax. We present the case of a 54 year-old man with multiple flesh-colored papules on his face confirmed histologically as fibrofolliculomas. He had a history of recurrent pneumothorax and chest computed tomography showed multiple lung cysts. To confirm the diagnosis of BHDS, we conducted gene analysis that revealed a single nucleotide duplication in the folliculin (FLCN) gene (Exon 11, C.1285dupC). BHDS confirmed by the FLCN gene mutation is rarely reported in Korea. Appropriate investigation is recommended whenever a patient with benign skin tumors is encountered.

Keywords: Birt-Hogg-Dubé syndrome, Fibrofolliculoma, Folliculin


Birt-Hogg-Dubé syndrome (BHDS) is an autosomal dominant condition characterized clinically by fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax and renal cancer. It is caused by germline mutations in the folliculin (FLCN) gene, detection of which confirm the diagnosis, but no correlation has been revealed between phenotypes and mutations. We report a 54-year-old male BHD patient with multiple, tiny, flesh-colored papules on both cheeks and multiple lung cysts with recurrent pneumothorax of the left lung.


A 54-year old man with asymptomtic, tiny, multiple, flesh-colored papules on both cheeks (Fig. 1) was referred to us from the cardiothoracic surgery department, where he had been treated for recurrent pneumothorax of the left lung. He did not remember the onset of the lesions, but stated that the number was increasing. He had no special medical or family history. The papules were thought to be sebaceous hyperplasia or verruca plana and a punch biopsy was performed. The specimen showed an epithelial cord and fibrous stroma in the dermis and an anastomosing band from follicular epithelium (Fig. 2). A diagnosis of fibrofolliculoma was made, which is the major feature of BHDS.

Fig. 1
Clinical features of fibrofolliculomas.
Fig. 2
Histopathology of fibrofolliculoma. (A) H&E stain, ×40. (B) H&E stain, ×100.

There was no family history of the skin lesions, lung disease, and of benign or malignant tumors. Furthermore, multiple variable-sized lung cysts were found on his chest following computed tomographic scan and a right renal cyst 2 cm in diameter was found on abdominal sonography (Fig. 3). Molecular analysis of FLCN was performed after informed consent from the patient. Sequencing revealed a single nucleotide frameshift duplication occurring within the polycytosine tract located in exon 11, c.1285dupC (p.H429Pfs*27), resulting in a change of the 429th amino acid from histidine to proline in the FLCN gene product. Based on this, it is possible to accurately diagnose BHDS.

Fig. 3
Imaging studies. (A) Multiple lung cysts found on chest computed tomography. (B) A right renal cyst found on abdominal sonography.

His pneumothorax was treated with thoracostomy and pleurodesis, and active treatment was not required for the skin lesions, lung cysts and renal cyst. He is on regular follow-up because renal and colorectal cancer can occur in this syndrome.


BHDS was first described in 1977 by three Canadian physicians who studied a family with several members affected by multiple skin fibrofolliculomas, trichodiscomas, and acrochordons1. Fibrofolliculoma, histologically verified, is one of the major features of this syndrome and can be accompanied by multiple lung cysts, spontaneous pneumothorax and renal cancer. The disease is caused by a mutation of the FLCN gene, which is located in chromosome position 17p11.2 and encodes for the folliculin protein. The function of this protein is predicted to exhibit tumor-suppressor activity but this is largely unverified2-4. Although the incidence is not yet established, about 200 families with BHDS containing pathogenic FLCN mutations have been reported worldwide2. Among these, an apparent difference in mutations were found, which include insertion, deletion, inactivating frameshift and nonsense mutations1,4. Because no genotype-phenotype correlation has been found to date and clinical expression is widely variable, BHDS is most likely under-diagnosed2,5.

Menko et al.2 suggested diagnostic criteria for BHDS (Table 1). Our patient had more than 10 fibrofolliculomas on the face, which were confirmed histologically, as well as multiple lung cysts with recurrent spontaneous pneumothorax. In addition, molecular analysis showed a mutation in the folliculin gene, c.1285dupC (p.H429Pfs*27), which had been reported previously6. Therefore, he fulfilled two major criteria and one minor criteria for BHDS diagnosis.

Table 1
Diagnostic criteria for Birt-Hogg-Dubé syndrome

Because of a 7-fold increased risk of developing renal tumors in BHDS-affected individuals, surveillance for renal cancer is indicated7. However, there are no established guidelines on what the optimum age is to start surveillance, the methods of examination, and the interval between examinations. Possible methods include ultrasonography, computed tomography, and magnetic resonance imaging. Our patient was advised to be screened every 6 to 12 months for renal cancer including consultation with a nephrologist.

Also, differential diagnosis is important, as firm, domeshaped papules that appear predominantly in the head and neck region can be seen in several tumor-related syndromes. These include angiofibromas in tuberous sclerosis, trichilemmomas in Cowden disease, and trichoepitheliomas in Brooke-Spiegler syndrome, etc8. Histologic examination of the lesions and thorough evaluation for concomitant systemic disease can differentiate BHDS from other disorders.

Management strategies currently are symptomatic and preventive2. Treatment for fibrofolliculomas using an erbium-YAG or fractional CO2 laser provides temporary improvement9-11. Individuals exposed to large ambient pressure differences such as piloting and deep-sea diving should be assessed by a pulmonary physician. Smoking, which is an important risk factor for both spontaneous pneumothorax and renal cancer, should be strongly discouraged. Further investigations such as the molecular analysis of the FLCN gene for patients suspected of BHDS and their 1st degree families should be strongly encourage.

In this study, we experienced a case of BHDS confirmed by genetic analysis, which has rarely been reported in Korea. Based on this case, it is important that physicians recognize facial papules that can be developed concurrently with systemic disease and conduct adequate studies to detect other features of the disease.


1. Leter EM, Koopmans AK, Gille JJ, van Os TA, Vittoz GG, David EF, et al. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families. J Invest Dermatol. 2008;128:45–49. [PubMed]
2. Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, Ungari S, et al. European BHD Consortium. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol. 2009;10:1199–1206. [PubMed]
3. Kim EH, Jeong SY, Kim HJ, Kim YC. A case of Birt-Hogg-Dubé syndrome. J Korean Med Sci. 2008;23:332–335. [PMC free article] [PubMed]
4. Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, et al. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet. 2005;76:1023–1033. [PubMed]
5. Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, et al. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet. 2010;47:281–287. [PMC free article] [PubMed]
6. Maffé A, Toschi B, Circo G, Giachino D, Giglio S, Rizzo A, et al. Constitutional FLCN mutations in patients with suspected Birt-Hogg-Dubé syndrome ascertained for non-cutaneous manifestations. Clin Genet. 2011;79:345–354. [PubMed]
7. Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11:393–400. [PubMed]
8. Vincent A, Farley M, Chan E, James WD. Birt-Hogg-Dubé syndrome: a review of the literature and the differential diagnosis of firm facial papules. J Am Acad Dermatol. 2003;49:698–705. [PubMed]
9. Kahle B, Hellwig S, Schulz T. Multiple mantleomas in Birt-Hogg-Dubé syndrome: successful therapy with CO2 laser. Hautarzt. 2001;52:43–46. [PubMed]
10. Jacob CI, Dover JS. Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. Arch Dermatol. 2001;137:98–99. [PubMed]
11. Gambichler T, Wolter M, Altmeyer P, Hoffman K. Treatment of Birt-Hogg-Dubé syndrome with erbium:YAG laser. J Am Acad Dermatol. 2000;43:856–858. [PubMed]

Articles from Annals of Dermatology are provided here courtesy of Korean Dermatological Association and Korean Society for Investigative Dermatology